The research group led by Professor Dr. Anne Seidlitz focuses on the development of innovative drug delivery systems and modern drug release testing methods.

A particular research emphasis is on the use of additive manufacturing techniques for the production of customizable dosage forms. The combination of hot-melt extrusion and 3D printing allows for precise control of drug release through material design, structural configuration, and manufacturing parameters. The goal is to contribute to patient-specific, safe, and effective pharmacotherapy.

Another key area of focus is the development of biorelevant in vitro release systems for parenteral dosage forms, including drug-eluting stents and depot formulations. Novel dissolution test methods – partly utilizing 3D-printed components – are employed to more accurately simulate physiological conditions. The aim here is to better understand drug release mechanisms from complex formulations and the influence of certain physiological conditions on the dosage form to support the development of new drug products through improved testing methods.

Prof. Dr. Anne Seidlitz